[144] Clearwater Analytics Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Insider sale notice for Clearwater Analytics Holdings, Inc. (CWAN) filed on Form 144 shows proposed and recent sales of common stock by an individual identified as James Cox and related 10b5-1 plans. The filer reports an intended sale of 11,275 shares with an aggregate market value of $218,396.75 to be sold on 08/15/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The 11,275 shares comprise 6,275 shares acquired on 08/15/2025 by exercising stock options (paid in cash) and 5,000 RSUs acquired on 02/21/2023. The notice also discloses three sales during the prior three months totaling 43,258 shares for gross proceeds of $963,715.97, including sales under a 10b5-1 plan.

Insights

Securities Analyst

TL;DR: Insider is selling newly exercised and previously vested shares, with recent 10b5-1 plan activity; overall impact appears routine and non-transactional.

The Form 144 indicates a planned sale of 11,275 common shares on 08/15/2025 executed through Morgan Stanley Smith Barney. Material details include 6,275 shares from an option exercise on the same date and 5,000 shares from RSU vesting in 2023. Recent history shows substantial dispositions in the last three months under both direct and 10b5-1 plan executions totaling 43,258 shares and roughly $964k gross proceeds. For investors, this filing documents liquidity actions by an insider rather than corporate operational changes; absent other disclosures, it is a disclosure of trading activity, not a signal of company fundamentals.

Corporate Governance Expert

TL;DR: Transactions are documented and include 10b5-1 plan sales and an option exercise; compliance representations are intact.

The filing lists broker details and includes the required representation that the seller is unaware of undisclosed material adverse information. The presence of 10b5-1 plan sales and same-day exercise-plus-sell activity is consistent with routine insider liquidity management. From a governance perspective, the form contains the expected confirmations and trading-plan date disclosures, but the filing does not provide plan adoption dates or additional narrative. This is a standard disclosure with no apparent procedural irregularities in the submitted fields.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11275	218396.75	287938740	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Exercise of Stock Options	Issuer			6275	08/15/2025	Cash
Common	02/21/2023	Restricted Stock Units	Issuer			5000	02/21/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	07/15/2025	18700	420693.41
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	06/30/2025	5858	126961.61
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	06/16/2025	18700	416060.95

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)